Home › Glioblastoma › Pennsylvania › Pittsburgh

Pag-aaral pangklinika para sa Glioblastoma sa Pittsburgh, PA

9 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Pittsburgh (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Nagre-recruitPhase 3

Allegheny Health Network, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07195591

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Nagre-recruitPhase 1/2

UPMC Hillman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Nagre-recruitPhase 2/3

University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT03970447

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Nagre-recruitPhase 2

UPMC Hillman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Nagre-recruitPhase 1

UPMC Hillman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

UPMC Hillman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Nagre-recruitPhase 2

University of Pittsburgh Medical Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT02977780

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Nagre-recruitPhase 2

UPMC Presbyterian Hospital, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06805305

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Nagre-recruitPhase 1

University of Pittsburg Medical Center (UPCM), Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05283330

Pag-aaral para sa Glioblastoma sa ibang lungsod

Iba pang pag-aaral sa Pittsburgh

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.